GBIO vs IONS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
GBIO
IONS
Investment Advisor Scores
IONS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GBIO | IONS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.874 | 90.9091 | GBIO |
| PEG Ratio | 0 | 25.7033 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -78.9% | 54.9% | IONS |
| Earnings Growth | 0.0% | -43.7% | GBIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 42.9/100 | 49.9/100 | IONS |
| Profit Margin | 0.0% | -56.9% | GBIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GBIO
NeutralMixed signals - no dominant trend phase, RSI 40
IONS
MarkdownPrice below a falling SMA50 (slope -13.9%), weak momentum, RSI 18
Fundamentals Snapshot
| Metric | GBIO | IONS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.7 | -22.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.8% | 0.5% |
| Gross Margin | -2.1% | 0.0% |
| Operating Margin | -20.2% | -0.5% |
| EPS | -9.37 | -3.35 |
| Dividend Yield | — | — |